FundedIQ
Biotechnology

Sapreme Technologies: Funding, Investors & Team (Aug 2026)

Sapreme Technologies is a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutic.

sapreme-technologies.com LinkedIn Bilthoven, Netherlands 1-10 employees
Biotechnology Life Science Pharmaceutical
Total raised
$17.3M
Rounds
1
Latest
Series A
Oct 2021

Sapreme Technologies has raised $17.3M across 1 funding round on record, the most recent a Series A of $17.3M announced in Oct 2021.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Sapreme Technologies Company Profile and Key Stats

Total funding raised
$17.3M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$17.3M in Oct 2021
Employees
1-10
reported band
Headquarters
Bilthoven, Netherlands

Latest funding round on record: Oct 2021.

Sapreme Technologies Funding Rounds

Date
Round
Amount
Series A
$17.3M

Sapreme Technologies Founders and Leadership Team

Name
Role
Contact
Guy Hermans
CEO
Locked

Contact details for the Sapreme Technologies team: 1 of 1 has an email address on file.

Start 14-day free trial →

Sapreme Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
740
$5.0M
8,352
$15M

Sapreme Technologies' latest round of $17.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Sapreme Technologies in Biotechnology and Bilthoven

Companies Similar to Sapreme Technologies

The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…

Series B $20.5M

Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…

Undisclosed round $45.4M

Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…

Undisclosed round $47.8M

Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…

Undisclosed round

Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…

Series B $28.3M

Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…

Undisclosed round $300M

Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…

Series B $60.0M

We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…

Undisclosed round $5.7M

QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.

Pre-Seed $2.4M

Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…

Undisclosed round $1.1M

QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…

Undisclosed round $2.6M

BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…

Seed $3.1M

Sapreme Technologies Funding FAQs

What does Sapreme Technologies do?

Sapreme Technologies is a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutic.

How much funding has Sapreme Technologies raised?

Sapreme Technologies has raised $17.3M across 1 round on record. The most recent is a Series A of $17.3M announced in Oct 2021.

When did Sapreme Technologies last raise funding?

Sapreme Technologies' most recent funding round on record is a Series A of $17.3M, announced in Oct 2021.

Who is the CEO of Sapreme Technologies?

Guy Hermans is listed as CEO at Sapreme Technologies.

Where is Sapreme Technologies headquartered?

Sapreme Technologies is based in Bilthoven, Utrecht, Netherlands.

How many employees does Sapreme Technologies have?

Sapreme Technologies is in the 1-10 employee band.

How does Sapreme Technologies' funding compare to other Biotechnology startups?

Sapreme Technologies' latest round of $17.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Sapreme Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sapreme Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.